tiprankstipranks
Trending News
More News >
Nomura Research InstituteLtd (JP:4307)
:4307
Advertisement

Nomura Research Institute (4307) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4307

Nomura Research Institute

(OTC:4307)

Rating:74Outperform
Price Target:
¥6,122.00
▲(10.83%Upside)
Nomura Research Institute exhibits strong financial performance with robust revenue growth and cash flow management. However, technical indicators suggest moderate bearish momentum, and a high P/E ratio raises concerns about valuation. The lack of recent earnings call data leaves out potential insights into future guidance.

Nomura Research Institute (4307) vs. iShares MSCI Japan ETF (EWJ)

Nomura Research Institute Business Overview & Revenue Model

Company DescriptionNomura Research Institute, Ltd. (NRI) is a leading think-tank and systems integrator company based in Japan. It operates across various sectors including consulting, financial IT solutions, industrial IT solutions, and IT infrastructure services. NRI offers a wide range of services such as management consulting, systems development, and IT infrastructure management, aiming to provide innovative solutions that enhance the operational efficiency and strategic capabilities of its clients.
How the Company Makes MoneyNRI generates revenue primarily through its four main business segments: Consulting, Financial IT Solutions, Industrial IT Solutions, and IT Infrastructure Services. The Consulting segment provides management and systems consulting services, deriving income from advisory fees. The Financial IT Solutions segment offers comprehensive IT services to financial institutions, including system development and maintenance, thereby earning from service contracts and software solutions. The Industrial IT Solutions segment caters to various industries, providing tailored IT services and solutions, generating revenue through project-based contracts and software implementation. Finally, the IT Infrastructure Services segment supports the operation and maintenance of IT systems and infrastructure, earning income through long-term service agreements. NRI's earnings are further bolstered by strategic partnerships with technology providers and continuous investment in developing advanced IT solutions.

Nomura Research Institute Financial Statement Overview

Summary
Nomura Research Institute demonstrates strong financial health with robust revenue growth, efficient cost management, and healthy profit margins. The balance sheet is solid with a stable leverage position and a strong equity base, though liabilities need monitoring. Cash flow generation is robust, ensuring operational flexibility and growth potential.
Income Statement
85
Very Positive
Nomura Research Institute has demonstrated strong revenue growth, evident from a consistent increase in total revenue over the years with a 3.84% growth in the latest year. The Gross Profit Margin is healthy at 35.98%, and the Net Profit Margin has improved to 12.26%, indicating efficient cost management. The EBIT and EBITDA margins at 17.16% and 24.58%, respectively, also reflect robust operational efficiency. Overall, the income statement shows a positive trajectory in profitability and revenue growth, suggesting good financial health.
Balance Sheet
78
Positive
The balance sheet of Nomura Research Institute shows a moderate Debt-to-Equity Ratio of 0.62, indicating a stable leverage position. The Return on Equity is impressive at 21.61%, suggesting effective use of equity to generate profits. The Equity Ratio stands at 46.75%, reflecting a strong equity base relative to total assets. Despite these strengths, a relatively high amount of total liabilities suggests potential leverage risks if not managed carefully. Overall, the balance sheet is solid with a strong equity position and good returns.
Cash Flow
82
Very Positive
The company's cash flow is robust, with Free Cash Flow growing significantly by 33.60%, showcasing strong cash generation capabilities. The Operating Cash Flow to Net Income Ratio is 1.39, indicating good cash flow relative to net income, while the Free Cash Flow to Net Income Ratio is 1.32, further reinforcing cash efficiency. These metrics highlight the company's ability to generate cash and meet its operational and investment needs efficiently. Overall, the cash flow statement reflects strong cash generation and management practices.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue764.81B736.56B692.16B611.63B550.34B
Gross Profit275.30B261.01B239.83B216.07B185.80B
EBITDA187.97B171.26B154.67B144.60B123.82B
Net Income93.76B79.64B76.31B71.44B52.87B
Balance Sheet
Total Assets928.50B922.77B838.22B789.65B656.54B
Cash, Cash Equivalents and Short-Term Investments168.60B173.94B143.46B129.63B163.03B
Total Debt271.02B298.54B237.74B250.42B165.59B
Total Liabilities490.54B519.75B435.82B447.17B323.33B
Stockholders Equity434.04B399.53B399.01B339.36B330.50B
Cash Flow
Free Cash Flow123.54B92.48B64.20B55.16B55.56B
Operating Cash Flow130.20B142.28B118.90B98.14B84.59B
Investing Cash Flow-47.59B-53.42B-61.19B-130.55B-20.52B
Financing Cash Flow-87.31B-47.58B-44.92B-8.00B-13.18B

Nomura Research Institute Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5524.00
Price Trends
50DMA
5664.92
Negative
100DMA
5434.93
Positive
200DMA
5120.26
Positive
Market Momentum
MACD
-74.00
Negative
RSI
51.29
Neutral
STOCH
73.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4307, the sentiment is Positive. The current price of 5524 is above the 20-day moving average (MA) of 5472.15, below the 50-day MA of 5664.92, and above the 200-day MA of 5120.26, indicating a neutral trend. The MACD of -74.00 indicates Negative momentum. The RSI at 51.29 is Neutral, neither overbought nor oversold. The STOCH value of 73.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4307.

Nomura Research Institute Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$5.66T31.738.97%0.67%-1.55%17.21%
74
Outperform
$3.14T33.7722.20%1.14%3.84%19.26%
74
Outperform
¥1.37T30.49
1.62%24.10%11.27%
73
Outperform
¥1.08T21.59
1.51%4.13%5.66%
65
Neutral
¥6.05T27.2111.70%0.85%-5.48%-10.98%
63
Neutral
$34.72B5.19-11.20%1.67%5.59%-16.73%
54
Neutral
¥5.56T39.007.94%0.63%6.21%6.41%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4307
Nomura Research Institute
5,524.00
879.05
18.92%
JP:3626
TIS Inc.
4,641.00
1,485.22
47.06%
JP:9719
SCSK Corporation
4,393.00
1,367.77
45.21%
JP:9613
NTT DATA
3,963.00
1,659.51
72.04%
JP:6701
NEC
4,172.00
1,596.29
61.97%
JP:6702
Fujitsu
3,290.00
570.45
20.98%

Nomura Research Institute Corporate Events

Nomura Research Institute Reports Strong Q1 Growth and Positive Outlook
Jul 28, 2025

Nomura Research Institute reported a 4.1% increase in revenue for the quarter ending June 30, 2025, with significant growth in operating profit and profit before tax. The company anticipates continued growth for the fiscal year ending March 31, 2026, with projected revenue and profit increases, reflecting a strong market position and positive outlook for stakeholders.

The most recent analyst rating on (JP:4307) stock is a Buy with a Yen6000.00 price target. To see the full list of analyst forecasts on Nomura Research Institute stock, see the JP:4307 Stock Forecast page.

Nomura Research Institute Affirms Independence Amidst Nomura Holdings Affiliation
Jun 23, 2025

Nomura Research Institute, Ltd. announced its relationship with Nomura Holdings, Inc., which holds 23% of NRI’s voting rights, establishing NRI as an affiliated company. Despite this affiliation, NRI operates independently without governance influence from Nomura HD, ensuring its business activities and management decisions remain autonomous. The announcement highlights NRI’s commitment to maintaining independence while continuing its collaborative efforts with Nomura HD, impacting stakeholders by reinforcing NRI’s strategic positioning in the market.

The most recent analyst rating on (JP:4307) stock is a Buy with a Yen6000.00 price target. To see the full list of analyst forecasts on Nomura Research Institute stock, see the JP:4307 Stock Forecast page.

Nomura Research Institute to Amend Articles for Governance Transition
May 14, 2025

Nomura Research Institute, Ltd. has announced its decision to amend its Articles of Incorporation to transition from a ‘Company with an Audit & Supervisory Board’ to a ‘Company with an Audit & Supervisory Committee.’ This change, set to be approved at the upcoming Ordinary General Meeting of Shareholders in June 2025, aims to streamline corporate governance by establishing new provisions for the committee and delegating decision-making powers to board members. This strategic move is expected to enhance operational efficiency and strengthen oversight, potentially impacting stakeholders by improving transparency and accountability within the company.

The most recent analyst rating on (JP:4307) stock is a Buy with a Yen6000.00 price target. To see the full list of analyst forecasts on Nomura Research Institute stock, see the JP:4307 Stock Forecast page.

Nomura Research Institute Announces Increased Dividend Payout
May 14, 2025

Nomura Research Institute announced a dividend payment from retained earnings, with a year-end dividend of ¥34 per share for the fiscal year ending March 31, 2025, reflecting an increase from the previous year. This decision aligns with NRI’s policy to provide stable dividends while aiming to improve capital efficiency and shareholder returns, with plans to increase the consolidated dividend payout ratio to 40% by March 2026.

The most recent analyst rating on (JP:4307) stock is a Buy with a Yen6000.00 price target. To see the full list of analyst forecasts on Nomura Research Institute stock, see the JP:4307 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 25, 2025